TFS Capital’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

TFS Capital’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-34,424	Closed	-$583K	–	1305
2014 Q4	$583K	Buy	+34,424	New	+$484K	0.06%	540
2014 Q3	–	Sell	-165,384	Closed	-$933K	–	1410
2014 Q2	$933K	Buy	+165,384	New	+$762K	0.07%	431

TFS Capital's AVNR Position: Q1 2015 in Review

TFS Capital sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 34,424 shares — an estimated $583K sold.

TFS Capital first reported a position in AVNR in Q2 2014 and held it in 2 quarters. The position peaked at $933K in Q2 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

TFS Capital reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
TFS Capital sold 34,424 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $583K.
TFS Capital first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2014 and held it in 2 quarters.
TFS Capital's AVANIR PHARMACEUTICALS, INC CL A position peaked at $933K in Q2 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on TFS Capital's 13F filing for Q1 2015, filed 29 Apr 2015.